NSE close · Tue, 29 SeptNifty 5022,716.20▼ 0.28%Nifty Bank54,259.95▼ 0.39%Midcap 10059,319.40▼ 0.99%Smallcap 25017,747.25▼ 0.65%India VIX13.41▼ 1.69%IT27,670.00▼ 1.48%Auto26,173.35▼ 1.33%Pharma26,933.65▲ 0.64%FMCG44,790.30▼ 1.05%Metal12,954.45▲ 0.78%Realty833.85▼ 2.00%Energy36,509.75▼ 0.50%PSU Bank7,972.80▼ 0.66%Financials24,648.50▼ 0.09%Media1,540.95▲ 0.11%Defence9,139.65▼ 0.99%Durables37,129.95▼ 2.71%Biggest movesDPABHUSHAN▲ 20.0%SYNCOMF▲ 17.9%FERMENTA▲ 15.0%MOMSBELIEF▲ 14.8%KIRLOSENG▲ 12.2%AUGMONT▲ 10.0%AXISCADES▲ 10.0%PRASOLCHEM▲ 10.0%

Top stories

Developing + Aurobindo Pharma · 1 storyClear filters

Developing 141 Picking up 33 Price moves 57 Following

Busiest tags today

AI175 Crude oil104 Bond yields90 Nifty and Sensex88 Global markets74 Geopolitics64 China52 US Treasuries51 Banks49 Pharma and healthcare48 Market valuations47 Gold46 Trade and tariffs43 RBI42 Every tag in Market pulse →

Company · AUROPHARMA

Aurobindo Pharma▲ +73% net tone today

2 stories today · 2 since 28 Sept₹1,697.70 · +0.01% on Tue, 29 Sept · −0.1% in 5 days

Often with, this weekPharma and healthcare2 GST1 Sun Pharma1 Taxes1 Trade and tariffs1

Open tag page →Clear ×

Stories per day

128 Sept

029 Sept

130 Sept

Policy▲Developing · 3

US exempts select Indian specialty drugs and ingredients from its 100% pharma tariff

The exemption covers certain specialty drugs and ingredients from India and 19 other countries
Eligible products include drugs for rare diseases, infertility treatments, cell therapies and gene therapies
Tariff relief supports US-facing specialty-drug sales at Sun Pharma and Aurobindo Pharma

Sun Pharma Aurobindo Pharma US tariffs Pharma and healthcare US drug pricing+17 sources · 14h

That’s everything for today